This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pimental, P. A. Articles by Hughes, J. R. Search for Related Content PubMed Articles by Pimental, P. A. Articles by Hughes, J. R. Social Bookmarking                         What's this?

Pseudoseizures and Pseudo-Toxicity Syndrome for Secondary Gain

Neurobehavioral Medicine Consultants, Ltd., Oak Brook, IL; Neurobehavioral Medicine Program at GlenOaks Hospital and Medical Center, Glendale Heights, IL; 701 Winthrop Avenue, Glendale Heights, IL 60139

Nabil Biary, MD

Riyadh Armed Forces Hospital, Riyadh, Saudi Arabia

Jesse Taber, MD

University of Illinois College of Medicine, Chicago, IL.

John R. Hughes, MD, PhD

Epilepsy Clinic; University of Illinois College of Medicine, Chicago, IL.

The clinical management of seizure disorders in prisoners often is difficult. This task is more challenging when a toxicity syndrome develops secondary to anti-convulsant therapy for epilepsy. Additionally, prisoners may develop pseudoseizures (PS) or pseudo-toxicity syndrome (PTS) for secondary gain. The co-occurrence of these disorders has not been reported previously in the literature. Since the above issues can be very complex, patients (especially prisoners) with PS and/or PTS appear to be best served by a biopsychosocial multi-disciplinary team approach for both diagnosis and treatment.

Journal of Correctional Health Care, Vol. 3, No. 1, 39-48 (1996)
DOI: 10.1177/107834589600300103


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?